Food and Drug Administration Drug Safety Podcast
FDA Drug Safety Podcast: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:03:00
- More information
Informações:
Synopsis
FDA Drug Safety Podcast: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C